Russian Heart Failure Journal 2009year Chronic heart failure and depressive disorders

To access this material please log in or register

Register Authorize

Chronic heart failure and depressive disorders

Vasyuk Y. A., Dovjenko T. V.

Keywords: depression, clinical symptoms, treatment, prognosis, CHF


Depressive disorders accompanies chronic heart failure (CHF) in more than 50% of cases. The presence of depression burdens CHF prognosis, combines with high morbidity and mortality, increases duration and costs of tratment. Use of modern antidepressants in patients with CHF and comorbididal depressive disorders along with improvement of mental condition significantly increases complex therapy efficacy, beneficially influence on 24 hours’ blood preassure profile, indices of intracardiac hemodynamics and of structure and geometry of left ventricle.
  1. Оганов Р. Г. Материалы симпозиума «Депрессия в кардиологии: больше, чем фактор риска», Российский национальный конгресс кардиологов. – М. 2003. С. 14.
  2. Koenig HG. Depression in hospitalized older patients with congestive heart failure. Gen Hosp Psychiatry. 1998; 20 (1):29–43.
  3. Krumholz HM, Butler J, Miller J et al. Prognostic importance of emotional support for elderly patients hospitalized with heart failure. Circulation. 1998; 97 (10):958–964.
  4. Nielsen OW, McDonagh T, Cowburn P et al. Patient differences related to management in general practice and the hospital: a cross-sectional study of heart failure in the community. Eur Heart J. 2004; 25 (19):1718–1725.
  5. Freedland KE, Carney RM, Rich MW et al. Depression in elderly patients with congestive heart failure. J Geriatr Psychiatry. 1991; 24 (1):59–71.
  6. Havranek EP, Ware MG, Lowes BD. Prevalence of depression in congestive heart failure. Am J Cardiol. 1999; 84 (3):348–350.
  7. Skotzko CE, Krichten C, Zietowski G et al. Depression is common and precludes accurate assessment of functional status in elderly patients with congestive heart failure. J Card Fail. 2000; 6 (4):300–305.
  8. Murberg TA, Furze G. Depressive symptoms and mortality in patients with congestive heart failure: a sixyear follow-up study. Med Sci Monit. 2004; 10 (12):CR643–648.
  9. Sullivan M, Levy WC, Russo JE, Spertus JA. Depression and health status in patients with advanced heart failure: a prospective study in tertiary care. J Card Fail. 2004; 10 (5):390–396.
  10. Gottlieb SS, Khatta M, Friedmann E et al. The influence of age, gender, and race on the prevalence of depression in heart failure patients. J Am Coll Cardiol. 2004; 43 (9):1542–1549.
  11. Sullivan M, Simon G, Spertus J, Russo J. Spertus depression related costs in heart failure care. Arch Intern Med. 2002; 162 (16):1860–1866.
  12. Fulop G, Strain JJ, Stettin G. Congestive heart failure and depression in older adults: clinical course and health services use 6 months after hospitalization. Psychosomatics. 2003; 44 (5):367–373.
  13. Jünger J, Schellberg D, Müller-Tasch T et al. Depression increasingly predicts mortality in the course of congestive heart failure. Eur J Heart Fail. 2005; 7 (2):261–267.
  14. Sullivan MD, Levy WC, Crane BA et al. Usefulness of depression to predict time to combined end point of transplant or death for outpatients with advanced heart failure. Am J Cardiol. 2004; 94 (12):1577–1580.
  15. Clary GL, Davenport C, Biracree D et al. Effects of antidepressant medication on mortality in patients with congestive heart failure (abstract). J Am Coll Cardiol 2002; 39 (suppl 1):168.
  16. Deanfield JE, Shea M, Kensett M et al. Silent myocardial ischaemia due to mental stress. Lancet. 1984; 2 (8410):1001–1005.
  17. Jiang W, Alexander J, Christopher E et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med. 2001; 161 (15):1849–1856.
  18. Himelhoch S, Weller WE, Wu AW et al. Chronic medical illness, depression, and use of acute medical services among Medicare beneficiaries. Med Care. 2004; 42 (6):512–521.
  19. Rumsfeld JS, Havranek E, Masoudi FA et al. Depressive symptoms are the strongest predictors of short term declines in health status in patients with heart failure. J Am Coll Cardiol. 2003; 42 (10):1811–1817.
  20. Carels RA. The association between disease severity, functional status, depression and daily quality of life in congestive heart failure patients. Qual Life Res. 2004; 13 (1):63–72.
  21. Sullivan MD, Newton K, Hecht J et al. Depression and health status in elderly patients with heart failure: a 6month prospective study in primary care. Am J Geriatr Cardiol. 2004; 13 (5):252–260.
  22. Gottdiener JS, Krantz DS, Howell RH et al. Induction of silent myocardial ischemia with mental stress testing: relation to the triggers of ischemia during daily life activities and to ischemic functional severity. J Am Coll Cardiol. 1994; 24 (7):1645–1651.
  23. Murberg TA, Bru E, Aarsland T, Svebak S. Functional status and depression among men and women with congestive heart failure. Int J Psychiatry Med. 1998; 28 (3):273–291.
  24. Vaccarino V, Kasl SV, Abramson J, Krumholz HM. Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol. 200; 38 (1):199–205.
  25. Juurlink DN, Herrmann N, Szalai JP et al. Medical illness and the risk of suicide in the elderly. Arch Intern Med. 2004; 164 (11):1179–1184.
  26. Plotsky PM, Owens MJ, Nemeroff CB. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatr Clin North Am. 1998; 21 (2):293–307.
  27. Jackson IM. The thyroid axis and depression. Thyroid. 1998; 8 (10):951–956.
  28. Maes M. The immunoregulatory effects of antidepressants. Hum Psycho­pharmacol. 2001; 16 (1):95–103.
  29. Veith RC, Lewis N, Linares OA et al. Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics. Arch Gen Psychiatry. 1994; 51 (5):411–422.
  30. Сыркин А. Л. Пациенты со стенокардией, резистентной к монотерапии антиангинальными препаратами. Consilium medicum. Экстра­выпуск. 2003. Октябрь. С. 5–7.
  31. Dinan T. Novel approaches to the treatment of depression by modulating the hypothalamic – pituitary – adrenal axis. Hum Psychopharmacol. 2001; 16 (1):89–93.
  32. Jacobson L, Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev. 1991; 12 (2):118–134.
  33. Wyatt RJ, Portnoy B, Kupfer DJ et al. Resting plasma catecholamine concentrations in patients with depression and anxiety. Arch Gen Psychiatry. 1971; 24 (1):65–70.
  34. Czéh B, Michaelis T, Watanabe T et al. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci USA. 2001; 98 (22):12796–12801.
  35. Maes M. The immunoregulatory effects of antidepressants. Hum Psycho­pharmacol. 2001; 16 (1):95–103
  36. Parissis JT, Adamopoulos S, Rigas A et al. Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression. Am J Cardiol. 2004; 94 (10):1326–1328.
  37. Young-Xu Y, Chan KA, Liao JK et al. Longterm statin use and psychological wellbeing. J Am Coll Cardiol. 2003; 42 (4):690–697.
  38. Paulus WJ. Cytokines and heart failure. Heart Fail Monit. 2000; 1 (2):50–6.
  39. Pasic J, Levy WC, Sullivan MD. Cytokines in depression and heart failure. Psychosom Med. 2003; 65 (2):181–193.
  40. Cassell EJ. Reaction to physical illness and hospitalisation. Psychiatry in General Practice, New York: Mc Graw- Hill Book Company, 1979.
  41. Perlman LV, Ferguson S, Bergum K et al. Precipitation of congestive heart failure: social and emotional factors. Ann Intern Med. 1971; 75 (1):1–7.
  42. Feenstra J, Grobbee DE, Jonkman FA et al. Prevention of relapse in patients with congestive heart failure: the role of precipitating factors. Heart. 1998; 80 (5):432–436.
  43. Giannuzzi P, Shabetai R, Imparato A et al. Effects of mental exercise in patients with dilated cardiomyopathy and congestive heart failure: An echocardiographic Doppler study. Circulation. 1991; 83 (Suppl 4):155–165.
  44. Chapuy P, Cuny G, Delomier Y et al. [Depression in elderly patients. Value of tianeptine in 140 patients treated for 1 year]. Presse Med. 1991; 20 (37):1844–1852.
  45. Lasnier C, Marey C, Lapeyre G et al. [Cardiovascular tolerance to tianeptine]. Presse Med. 1991; 20 (37):1858–1863.
  46. Grignani G, Soffiantino F / , Zucchella M et al. Platelet activation by emotional stress in patients with coronary artery disease. Circulation. 1991; 83 (Suppl II):128–136.
  47. Allen MT, Patterson SM. Hemoconcentration and stress: a review of physiological mechanisms and relevance for cardiovascular disease. Biol Psychol. 1995; 41 (1):1–27.
  48. Lowe GD, Lee AJ, Rumley A et al. Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. Br J Haematol. 1997; 96 (1):168–173.
  49. Scherrer JF, Xian H, Bucholz KK et al. A twin study of depression symptoms, hypertension, and heart disease in middle-aged men. Psychosom Med. 2003; 65 (4):548–557.
  50. Baghai TC, Binder EB, Schule C et al. Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism. Mol Psychiatry. 2006; 11 (11):1003–1015.
  51. Jezova D, Ochedalski T, Kiss A, Aguilera G. Brain angiotensin II modulates sympathoadrenal and hypothalamic pituitary adrenocortical activation during stress. J Neuroendocrinol. 1998; 10 (1):67–72.
  52. Murck H, Held K, Ziegenbein M et al. The renin-angiotensin-aldosterone system in patients with depression compared to controls - a sleep endocrine study. BMC Psychiatry. 2003; 3:15.
  53. Gard PR. Angiotensin as a target for the treatment of Alzheimer’s disease, anxiety and depression. Expert Opin Ther Targets. 2004; 8 (1):7–14.
  54. Braunwald: Heart Disease: A Textbook of Cardiovascular Medicine, 6th ed, 2001 W. B. Saunders Company. Chapter 70.
  55. Tylee AT, Freeling P, Kerry S. Why do general practitioners recognize major depression in one woman patient yet miss it in another? Br J Gen Pract. 1993; 43 (373):327–330.
  56. Elkin I, Shea MT, Watkins JT et al. National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments. Arch Gen Psychiatry. 1989; 46 (11):971–982.
  57. Paykel ES. Life events, social support and depression. Acta Psychiatr Scand Suppl. 1994; 377:50–58.
  58. Shapiro PA, Lespérance F, Frasure-Smith N et al. An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Sertraline Anti-Depressant Heart Attack Trial. Am Heart J. 1999; 137 (6):1100–1106.
  59. Дробижев М. Ю., Сыркин А. Л., Полтавская М. Г. и др. Лечение тианептином (коаксилом) тревожных депрессий у больных ишемической болезнью сердца. Журнал неврологии и психиатрии им. С. С. Корсакова. 2000; 100 (4):44–47.
  60. Marey C, Delalleau B, Lemoine P, Ganry H. La tianeptine, une acceptabilite inhabituelle poor un antidepresseur efficace. Jama, French. edition, 1990 – Special issue. – P. 66–71.
  61. Васюк Ю. А., Нестерова Е. А., Довженко Т. В., Садулаева И. А. Совре­менные антидепрессанты в комплексном лечении больных с АГ с сопутствующими аффективными расстройствами. Кардиология. 2004; 44 (8):72–79.
  62. Васюк Ю. А., Довженко Т. В., Школьник Е. Л. Депрессии при хрони­ческой сердечной недостаточности ишемического генеза. Журнал Сердечная Недостаточность. 2004; 5 (3):140–147.
  63. Васюк Ю. А., Краснов В. Н., Довженко Т. В. и др. Антидепрессанты коаксил и золофт в комплексном лечении больных артериальной гипертензией с расстройствами аффективного спектра. Российский медицинский журнал. 2004; 1:15–19.
  64. Васюк Ю. А, Довженко Т. В, Тарасова К. В. и др. Хроническая сердечная недостаточность ишемического генеза и расстройства аффективного спектра. Сердце. 2003; 4 (6):304–306.
  65. Васюк Ю. А., Лебедев А. В., Иванова С. В. и др. Депрессия при инфаркте миокарда – фактор или маркер риска? Российский медицинский журнал. 2006; 3:47–49.

To access this material please log in or register

Register Authorize
Ru En